MedTrace Logo

Stopping Heavy Periods Project

NCT02002260 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2021-08-02

No results posted yet for this study

Summary

This study is a randomized clinical trial comparing the effectiveness of the levonorgestrel intrauterine system (LNG-IUS) to combined oral contraceptives (COCs) for improving quality of life among women who report heavy menstrual bleeding.

Conditions

  • Abnormal Uterine Bleeding
  • Abnormal Uterine Bleeding, Ovulatory Dysfunction
  • Abnormal Uterine Bleeding, Endometrial Hemostatic Dysfunction

Interventions

DEVICE

Levonorgestrel intrauterine system

DRUG

Combined oral contraceptives

Sponsors & Collaborators

  • Women and Infants Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Kristen A Matteson, M.D., M.P.H. · Women and Infants Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
51 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2019-06-16
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02002260 on ClinicalTrials.gov